litlas
Log inCreate account

James R. Baker

Active 1967–2026

Also published as
James R Baker
159
Papers
25,420
Citations
87
h-index
152
i10-index

Citations

Citations per year for James R. Baker1987: 2 citations1988: 2 citations1989: 2 citations1990: 4 citations1991: 7 citations1992: 12 citations1993: 16 citations1994: 24 citations1995: 11 citations1996: 15 citations1997: 21 citations1998: 25 citations1999: 50 citations2000: 82 citations2001: 69 citations2002: 72 citations2003: 64 citations2004: 129 citations2005: 163 citations2006: 189 citations2007: 299 citations2008: 343 citations2009: 385 citations2010: 432 citations2011: 377 citations2012: 312 citations2013: 289 citations2014: 274 citations2015: 282 citations2016: 208 citations2017: 184 citations2018: 210 citations2019: 489 citations2020: 469 citations2021: 500 citations2022: 374 citations2023: 281 citations2024: 386 citations2025: 213 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,801 citing papers, 27.1% of this breakdownChina: 883 citing papers, 13.3% of this breakdownIndia: 405 citing papers, 6.1% of this breakdownUnited Kingdom: 346 citing papers, 5.2% of this breakdownGermany: 241 citing papers, 3.6% of this breakdownItaly: 194 citing papers, 2.9% of this breakdownSouth Korea: 194 citing papers, 2.9% of this breakdownFrance: 176 citing papers, 2.6% of this breakdownAustralia: 163 citing papers, 2.5% of this breakdownCanada: 143 citing papers, 2.1% of this breakdownSpain: 139 citing papers, 2.1% of this breakdownIran: 135 citing papers, 2% of this breakdown
0%27.1%Other 27.6%

Institutions

Fields

  • Materials Science29.8%
  • Biochemistry, Genetics and Molecular Biology25.8%
  • Medicine22.1%
  • Immunology and Microbiology5.8%
  • Engineering4.7%
  • Chemistry3.8%
  • Other8%

Topics

  • RNA Interference and Gene Delivery9.8%
  • Nanoparticle-Based Drug Delivery6.6%
  • Advanced biosensing and bioanalysis techniques6%
  • Dendrimers and Hyperbranched Polymers5.8%
  • Nanoplatforms for cancer theranostics2.5%
  • Monoclonal and Polyclonal Antibodies Research2.4%
  • Other66.9%

Coauthors

All papers

Open in search
  1. Antibody–PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4

    Authors: Marı́a Maneiro, Nafsika Forte, Maria M. Shchepinova, Cyrille S. Kounde, Vijay Chudasama, James R. Baker, Edward W. Tate - ACS Chemical Biology 2020 cited by 324

  2. Applications of nanotechnology for immunology

    Authors: Douglas M. Smith, Jakub K. Simon, James R. Baker - Nature reviews. Immunology 2013 cited by 759

  3. Site-selective lysine conjugation methods and applications towards antibody–drug conjugates

    Authors: Muhammed Haque, Nafsika Forte, James R. Baker - Chemical Communications 2021 cited by 111

  4. The unfulfilled potential of mucosal immunization

    Authors: James R. Baker, Mohammad Farazuddin, Pamela T. Wong, Jessica J. O’Konek - Journal of Allergy and Clinical Immunology 2022 cited by 78

  5. The Binding Avidity of a Nanoparticle-Based Multivalent Targeted Drug Delivery Platform

    Authors: Seungpyo Hong, Pascale R. Leroueil, István Majoros, Bradford G. Orr, James R. Baker, Mark M. Banaszak Holl - Chemistry & Biology 2007 cited by 588

  6. Hypersensitivity reactions from taxol.

    Authors: R B Weiss, Ross C. Donehower, Peter H. Wiernik, T Ohnuma, R. Gralla, D L Trump, James R. Baker, David A. Van Echo, Daniel D. Von Hoff, B Leyland-Jones - Journal of Clinical Oncology 1990 cited by 1,177

  7. Protein Modification, Bioconjugation, and Disulfide Bridging Using Bromomaleimides

    Authors: Mark E. B. Smith, Felix Schumacher, Chris P. Ryan, Lauren Tedaldi, Danai Papaioannou, Gabriel Waksman, Stephen Caddick, James R. Baker - Journal of the American Chemical Society 2010 cited by 374

  8. Folate‐targeted nanoparticles show efficacy in the treatment of inflammatory arthritis

    Authors: Thommey P. Thomas, Sascha N. Goonewardena, István Majoros, Alina Kotlyar, Zhengyi Cao, Pascale R. Leroueil, James R. Baker - Arthritis & Rheumatism 2011 cited by 207

  9. Nanoparticle Targeting of Anticancer Drug Improves Therapeutic Response in Animal Model of Human Epithelial Cancer

    Authors: Jolanta F. Kukowska‐Latallo, Kimberly A. Candido, Zhengyi Cao, Shraddha S. Nigavekar, István Majoros, Thommey P. Thomas, Lajos Balogh, Mohamed K. Khan, James R. Baker - Cancer Research 2005 cited by 898

  10. Interaction of Polycationic Polymers with Supported Lipid Bilayers and Cells: Nanoscale Hole Formation and Enhanced Membrane Permeability

    Authors: Seungpyo Hong, Pascale R. Leroueil, Elizabeth K. Janus, Jennifer L. Peters, Mary-Margaret Kober, Mohammad T. Islam, Bradford G. Orr, James R. Baker, Mark M. Banaszak Holl - Bioconjugate Chemistry 2006 cited by 683

  11. Interaction of Poly(amidoamine) Dendrimers with Supported Lipid Bilayers and Cells: Hole Formation and the Relation to Transport

    Authors: Seungpyo Hong, Anna U. Bielinska, Almut Mecke, B. Keszler, James Beals, Xiangyang Shi, Lajos Balogh, Bradford G. Orr, James R. Baker, Mark M. Banaszak Holl - Bioconjugate Chemistry 2004 cited by 598

  12. A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine

    Authors: Sonia Jangra, Jeffrey J. Landers, Raveen Rathnasinghe, Jessica J. O’Konek, Katarzyna Janczak, Marília Cascalho, Andrew A. Kennedy, Andrew W. Tai, James R. Baker, Michael Schotsaert, Pamela T. Wong - Frontiers in Immunology 2021 cited by 38

  13. Wide Varieties of Cationic Nanoparticles Induce Defects in Supported Lipid Bilayers

    Authors: Pascale R. Leroueil, Stephanie A. Berry, Kristen Duthie, Gang Han, Vincent M. Rotello, Daniel Q. McNerny, James R. Baker, Bradford G. Orr, Mark M. Banaszak Holl - Nano Letters 2008 cited by 551

  14. Nanoparticle Interaction with Biological Membranes: Does Nanotechnology Present a Janus Face?

    Authors: Pascale R. Leroueil, Seungpyo Hong, Almut Mecke, James R. Baker, Bradford G. Orr, Mark M. Banaszak Holl - Accounts of Chemical Research 2007 cited by 542

  15. Next generation maleimides enable the controlled assembly of antibody–drug conjugatesvianative disulfide bond bridging

    Authors: Felix Schumacher, João P. M. Nunes, Antoine Maruani, Vijay Chudasama, Mark E. B. Smith, Kerry Chester, James R. Baker, Stephen Caddick - Organic & Biomolecular Chemistry 2014 cited by 166

  16. Polyvalent Dendrimer-Methotrexate as a Folate Receptor-Targeted Cancer Therapeutic

    Authors: Thommey P. Thomas, Baohua Huang, Seok Ki Choi, Justin E. Silpe, Alina Kotlyar, Ankur Desai, Hong Zong, Jeremy J. Gam, M. Vimala Joice, James R. Baker - Molecular Pharmaceutics 2012 cited by 143

  17. Cationic Nanoparticles Induce Nanoscale Disruption in Living Cell Plasma Membranes

    Authors: Jiumei Chen, Jessica A. Hessler, Krishna Putchakayala, Brian K. Panama, Damian P. Khan, Seungpyo Hong, Douglas G. Mullen, Stassi DiMaggio, Abhigyan Som, Gregory N. Tew, Anatoli N. Lopatin, James R. Baker, Mark M. Banaszak Holl, Bradford G. Orr - The Journal of Physical Chemistry B 2009 cited by 227

  18. Functionalized nanoparticles with targeted antibody to enhance imaging of breast cancer in vivo

    Authors: Jesse S. Chen, Jingwen Chen, Somnath Bhattacharjee, Zhengyi Cao, Han Wang, Scott D. Swanson, Hong Zong, James R. Baker, Su He Wang - Journal of Nanobiotechnology 2020 cited by 41

  19. Leucine-rich alpha-2-glycoprotein 1 (LRG1) as a novel ADC target

    Authors: Faiza Javaid, Camilla Pilotti, Carlotta Camilli, David Kallenberg, Calise Bahou, Jack Blackburn, James R. Baker, John A. Greenwood, Stephen E. Moss, Vijay Chudasama - RSC Chemical Biology 2021 cited by 31

  20. Combined Intranasal Nanoemulsion and RIG-I Activating RNA Adjuvants Enhance Mucosal, Humoral, and Cellular Immunity to Influenza Virus

    Authors: Pamela T. Wong, Peter H. Goff, Rachel Sun, Matthew J. Ruge, Megan E. Ermler, Alyssa Sebring, Jessica J. O’Konek, Jeffrey J. Landers, Katarzyna Janczak, Weina Sun, James R. Baker - Molecular Pharmaceutics 2020 cited by 28

  21. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers.

    Authors: Jolanta F. Kukowska‐Latallo, Anna U. Bielinska, James M. Johnson, Ralf Spindler, Donald A. Tomalia, James R. Baker - National Academy of Sciences, Proceedings of the National Academy of Sciences 1996 cited by 1,002

  22. Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor

    Authors: Antonio Dı́az-Quintana, Ewa Raczka, Lars T. Piehler, Inhan Lee, Andrzej Myc, István Majoros, Anil K. Patri, Thommey P. Thomas, James J. Mulé, James R. Baker - Pharmaceutical Research 2002 cited by 661

  23. PAMAM Dendrimer-Based Multifunctional Conjugate for Cancer Therapy: Synthesis, Characterization, and Functionality

    Authors: István Majoros, Andrzej Myc, Thommey P. Thomas, Chandan Mehta, James R. Baker - Biomacromolecules 2006 cited by 591

  24. Dendritic polymer macromolecular carriers for drug delivery

    Authors: Anil K. Patri, István Majoros, James R. Baker - Current Opinion in Chemical Biology 2002 cited by 591